Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
6.97 Quote: soon again about $2 - well over $40 - just sick whoever bought it
The pump hasn’t even started. Hold.
They’ve increased the float by about 4 million in the last couple of weeks. Closer to 10 million now.
Looks like this will hang in this region or slowly bleed back to 5’s unless more stellar news is released.
Wow they are really keeping the price suppressed
Sounds like fun!
Yes interesting read they are
VTGN twitter account: nearly 19,000 followers.
follow this account on twitter to stay informed:
https://twitter.com/Vistagen
$VTGN setting up for a nice bounce, there’s lots of momentum back on these kind of setups. Don’t sleep on it bulls!
— Top Stock Alerts (@TopStockAlerts1) August 9, 2023
$13 possible today.
Tiny float.
New price target: $30
Earnings tomorrow
Institutional ownership: over 10 percent
Maxim Group Upgrades Vistagen Therapeutics to Buy, Announces $30 Price Target
7:09 pm ET August 7, 2023 (Benzinga) Print
Maxim Group analyst Jason McCarthy upgrades Vistagen Therapeutics (NASDAQ:VTGN) from Hold to Buy and announces $30 price target.
Latest Ratings for VTGN DateFirmActionFromTo
May 2021BairdInitiates Coverage OnOutperform Feb 2021JefferiesInitiates Coverage OnBuy Jan 2021William BlairUpgradesMarket PerformOutperform
View More Analyst Ratings for VTGN
View the Latest Analyst Ratings
Vistagen Announces Positive Top-Line Results from Phase 3
PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social
Anxiety Disorder
First positive U.S. Phase 3 study of an investigational therapy for social anxiety disorder in over 15 years
Statistically significant rapid-onset reduction in patient-reported Subjective Units of Distress Scale (SUDS) score compared to placebo in a public speaking challenge (primary endpoint, p=0.015)
Trial also met the secondary endpoint, demonstrating a statistically significant reduction in proportion of responders compared to placebo as measured by the Clinical Global Impressions Improvement (CGI-I) scale (secondary endpoint, p=0.033)
Fasedienol was well-tolerated and demonstrated a favorable safety profile consistent with all prior trials of fasedienol in social anxiety disorder
Over 25 million Americans are living with social anxiety disorder1
Don’t shorts suck? This one has already been through all the ringers. Cya over $100.
Partner? Payment? Projections?
Yeah I figured that
Evidently not
Press Release: Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023
5:19 pm ET August 8, 2023 (Dow Jones) Print
Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--August 08, 2023--
Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced it will host a conference call and webcast on Thursday, August 10, 2023, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to provide a corporate update and report results for its fiscal year 2024 first quarter ended June 30, 2023.
Event: Vistagen Fiscal Year 2024 First Quarter Corporate Update Conference Call
Date: Thursday, August 10, 2023
Time: 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time)
US Dial-in (Toll-free): 1-800-954-1051
TOLL/International Dial-in: 1-212-231-2924
Conference ID: 22027732
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1627439&tp_key=9f0f4cb009
Maxim Group Upgrades Vistagen Therapeutics to Buy, Announces $30 Price Target
7:09 pm ET August 7, 2023 (Benzinga) Print
Maxim Group analyst Jason McCarthy upgrades Vistagen Therapeutics (NASDAQ:VTGN) from Hold to Buy and announces $30 price target.
Latest Ratings for VTGN DateFirmActionFromTo
May 2021BairdInitiates Coverage OnOutperform Feb 2021JefferiesInitiates Coverage OnBuy Jan 2021William BlairUpgradesMarket PerformOutperform
View More Analyst Ratings for VTGN
View the Latest Analyst Ratings
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
More like $3.00
Yep.
This should skyrocket tomorrow.
It had to find a bottom and support.
Newest rating: its a buy
And they raised the price target to $30
Subtract a 0 u now have 3$ price target lol
Price target is $30 now.
Lot of investment advisories are calling it a strong buy.
This will blow up sky high.
VTGN Now looking like a shorts dream, probably due for another bounce in next few days
ouch $ 40 now 9 $ . target $ 2
say again?? short are fucked, opening at .25??? that means shorts are doing great...
Not happening today
Investment advisory services/companies did raise the price target to $30.
Yep. Let’s see how it goes tomorrow.
I might more if it dips a little.
MIGHT / MIGHT NOT BE IMMEDIATELY. JUST ROCKETED $60
Price target just raised to $30.
Also just rated a strong buy.
Shorts are fucked.
Load and hold.
This open at .25 in the morning.
Get in and stay in.
This has another massive explosion coming.
I just bought more.
I am looking for $20.
Another dipwad heard from
you are always late. no matter what Share.
But your wife will certainly be very grateful to you for being late
haha
But you are a top short tipster
Thanks
Roaring Kitty Game over
2021 last
https://twitter.com/TheRoaringKitty
https://www.youtube.com/@RoaringKitty
This looks like it is fixing to explode.
I might grab a few more.
Without proof it is all big talk.
IG
$60 premarket for a minute then dropped backed to $12.
Why don't you post proof you sold at $60 - remember Roaring Kitty posted a screenshot of all of his trades on GME - post a screenshot of your account - just pixelate out personal information - my guess is you do this a great deal post about a great sell 8 hours after the fact.
Just more big talk.
IG
No it shouldn’t
The huge one day trading profits were made after 7am
Thanks to one heck of a wash trade bot
The most sensible thing for a trader to do is borrow shares
Followers
|
106
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
5006
|
Created
|
08/26/11
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |